Risperidone versus haloperidol in children and adolescents with AD: A randomized, controlled, double-blind trial - Miral, Suha; Gencer, Ozlem; Inal-Emiroglu, F. Neslihan; Baykara, Burak; Baykara, Aysen; Dirik, Eray (European child & adolescent psychiatry, 2008)
Keywords: Adolescent; Alanine Transaminase - blood; Antipsychotic Agents - adverse effects; Antipsychotic Agents - therapeutic use; Autistic Disorder - diagnosis; Autistic Disorder - drug therapy; Autistic Disorder - psychology; Biological and medical sciences; Child; Child and Adolescent Psychiatry; Child Behavior Disorders - diagnosis; Child Behavior Disorders - drug therapy; Child clinical studies; Developmental disorders; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced - etiology; Female; Humans; Infantile autism; Male; Medical sciences; Medicine; Medicine & Public Health; Neuropharmacology; Original Contribution; Outcome Assessment (Health Care); Personality Assessment; Pharmacology. Drug treatments; Prolactin - blood; Psychiatry; Psycholeptics: tranquillizer, neuroleptic; Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Psychopharmacology; Risperidone - adverse effects; Risperidone - therapeutic use; haloperidol; treatment; autistic disorder; risperidone; Human; Atypical antipsychotic; Psychotropic; Neuroleptic; Dopamine antagonist; Serotonin antagonist; Butyrophenone derivatives; Developmental disorder; Serotonine receptor; Haloperidol; Autism; D2 Dopamine receptor; Treatment; Adolescent; Double blind study; Risperidone; Child; Benzisoxazole derivatives; Comparative study